Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Jan 30;94(2):231-8.
doi: 10.1038/sj.bjc.6602914.

Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study

H M Verkooijen  1 , P O Chappuis, E Rapiti, G Vlastos, G Fioretta, S Sarp, A P Sappino, H Schubert, C Bouchardy
Affiliations
Comparative Study

Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study

H M Verkooijen et al. Br J Cancer. .

Abstract

This population-based study evaluates the impact of a strong family history of breast cancer on management and survival of women with early-onset disease. We identified all breast cancer patients </=50 years, recorded between 1990 and 2001 at the Geneva familial breast cancer registry. We compared patients at high familial risk and low familial risk in terms of tumour characteristics, method of detection, treatment, survival and breast cancer mortality risk. Compared to patients at low familial risk (n=575), those at high familial risk (n=58) received significantly more often systemic therapy, especially for node-negative or receptor-positive disease. Five-year disease-specific survival rates of patients at high vs low familial risk were 86 and 90%, respectively. After adjustment, there was no difference in breast cancer mortality in general. A strong family history nonsignificantly increased breast cancer mortality in patients </=40 years (adjusted hazard ratio (HR) 4.0, 95% CI 0.8-19.7) and in patients treated without chemotherapy (adjusted HR 2.7, 95% CI 0.6-12.5). A strong family history of breast cancer is associated with an increased use of systemic therapy in early-onset patients. Although a strong family history does not seem to affect survival in general, it may impair survival of very young patients and patients treated without adjuvant chemotherapy. Owing to the limited number of patients in this study, these results should be used only to generate hypotheses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Breast cancer-specific survival for young women (⩽50 years) at highly increased familial risk and women at low familial risk.
See this image and copyright information in PMC

References

    1. Bouchardy C (1997) Switzerland, Geneva. In: Cancer Incidence in Five Continents Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds). Vol. VII, pp 666–669. Lyon: International Agency for Research on Cancer
    1. Bouchardy C, Verkooijen HM, Chappuis P, Vlastos G, Schäfer P, Kurtz J, Benhamou S, Sappino AP (2002) Occurrence and impact of genetic factors in breast cancer among the female population in Geneva: creation of the Geneva familial breast cancer registry. Bull Suisse Cancer 2650: 165–168
    1. Breast Cancer Linkage Consortium (1997) Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349: 1505–1510 - PubMed
    1. Brekelmans CT, Seynaeve C, Bartels CC, Tilanus-Linthorst MM, Meijers-Heijboer EJ, Crepin CM, van Geel AA, Menke M, Verhoog LC, van den OA, Obdeijn IM, Klijn JG (2001) Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19: 924–930 - PubMed
    1. Chappuis PO, Rosenblatt J, Foulkes WD (1999) The influence of familial and hereditary factors on the prognosis of breast cancer. Ann Oncol 10: 1163–1170 - PubMed

Publication types